22.23
Roivant Sciences Ltd (ROIV) 最新ニュース
Capricorn Fund Managers Ltd Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Insider Confidence In December 2025's Leading Growth Companies - Yahoo! Finance Canada
Reassessing Roivant Sciences (ROIV) Valuation After Pipeline Progress, NDA Timelines and Genevant Litigation Updates - simplywall.st
Voya Investment Management LLC Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Is Roivant Sciences Ltd stock positioned for digital transformationGap Down & High Conviction Trade Alerts - moha.gov.vn
What margin trends mean for Roivant Sciences Ltd. stockFibonacci Extensions & Fast Profit Trading Tips - bollywoodhelpline.com
Ramaswamy-Backed Ambros Launches with $125M - Orange County Business Journal
Roivant Sciences president Sukhatme sells $619k in shares By Investing.com - Investing.com Australia
Roivant Sciences president Sukhatme sells $619k in shares - Investing.com UK
How Investors May Respond To Roivant Sciences (ROIV) Accelerating Brepocitinib Timelines And Patent Litigation - simplywall.st
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock - MSN
Why Roivant Sciences Ltd. stock is in analyst buy zone2025 Fundamental Recap & Reliable Entry Point Trade Alerts - Улправда
US Market Recap: What margin trends mean for Roivant Sciences Ltd stockJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - moha.gov.vn
Sell Signal: Will Roivant Sciences Ltd stock maintain momentum in 2025Weekly Stock Report & Pattern Based Trade Signal System - moha.gov.vn
Why Roivant Sciences Ltd. stock could be next big winner2025 Trading Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Can Roivant Sciences Ltd. stock maintain operating marginsJuly 2025 Chart Watch & Accurate Buy Signal Notifications - Улправда
How Roivant Sciences Ltd. (87S) stock reacts to fiscal policiesJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Roivant Sciences (NASDAQ:ROIV) Insider Mayukh Sukhatme Sells 26,831 Shares - MarketBeat
Pres Sukhatme Sells 26,831 ($619.5K) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Can Roivant Sciences Ltd. stock double in next 5 yearsWeekly Market Summary & Daily Technical Stock Forecast Reports - ulpravda.ru
Can Roivant Sciences Ltd. stock outperform in 2025 bull marketMarket Activity Summary & High Conviction Buy Zone Alerts - DonanımHaber
Why Roivant Sciences Ltd. stock remains undervaluedVolume Spike & Consistent Return Strategy Ideas - Bölüm Sonu Canavarı
Will Roivant Sciences Ltd. stock maintain momentum in 2025Weekly Stock Analysis & Long-Term Growth Plans - DonanımHaber
Roivant Sciences Insider Sold Shares Worth $39,065,213, According to a Recent SEC Filing - marketscreener.com
Published on: 2025-12-19 09:31:09 - ulpravda.ru
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Roivant Sciences (NASDAQ:ROIV) Director Daniel Allen Gold Sells 777,332 Shares - MarketBeat
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Director Sells 917,282 Shares of Stock - MarketBeat
Roivant Sciences (ROIV) director discloses indirect sales of common shares - Stock Titan
Owner QVT Financial LP Sells 1,694,614 ($39.1M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Drop Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Why analysts remain bullish on Roivant Sciences Ltd. stock2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Published on: 2025-12-18 16:03:55 - Улправда
Roivant Sciences Insider Sold Shares Worth $37,723,200, According to a Recent SEC Filing - marketscreener.com
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - The Motley Fool
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CEO Sells 1,740,000 Shares of Stock - MarketBeat
Pres Sukhatme Files To Sell 26,831 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Valeo Financial Advisors LLC Purchases New Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighShould You Buy? - MarketBeat
Roivant Sciences (ROIV): Reassessing Valuation After Bullish Pipeline and Patent Milestone Updates - simplywall.st
Leerink Partners Maintains Roivant Sciences (ROIV) Outperform Recommendation - Nasdaq
Roivant Sciences stock hits all-time high at 22.45 USD By Investing.com - Investing.com Australia
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $16,752,432.88 in Stock - MarketBeat
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares By Investing.com - Investing.com South Africa
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares - Investing.com
Owner Ramaswamy Sells 3,103,745 ($67.9M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
CEO Gline Files To Sell 1,740,000 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402Has The Bull Case Changed? - Yahoo! Finance Canada
Roivant Sciences (NASDAQ:ROIV) Given New $33.00 Price Target at The Goldman Sachs Group - MarketBeat
Roivant Sciences stock price target raised to $26 from $23 at H.C. Wainwright - Investing.com Australia
大文字化:
|
ボリューム (24 時間):